Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Posts tagged Camson Bio-Tech

Dharmesh Kant Recommends “High Quality Proxy Play” Stock With Huge Upside Potential



Dharmesh Kant, now with Motilal Oswal, is diligently discharging his responsibility of identifying winning stocks and recommending them to us. He has now homed in on a top-quality stock which stands to benefit from the demand for specialty chemicals and pharmaceuticals

Check Out Dharmesh Kant’s Latest Stock Pick. Will It Be A Big Winner Like MPS & Force Motors?



Dharmesh Kant’s latest stock pick is a top-quality and well managed company with a long and successful track record. It enjoys a high “entry barrier” and a “moat” and has high return ratios

IndiaNivesh Sells A Truckload Of Camson Bio-Tech Stock. Should We Be Worried?



Today, there was great excitement in the air over the news that IndiaNivesh had sold off a huge chunk of Camson Bio-Tech, a stock earlier recommended by them. Have they lost confidence in the stock and does it spell doom for us?

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 495 other subscribers

RSS Stocks Talk Forum

  • Sunil Singhania & Madhu Kela are bullish about Himatsingka Seide
    Sunil Singhania & Madhu Kela are bullish about Himatsingka Seide. Singhania's Abakkus Fund holds 6.78% worth ₹137 Cr. Kela's Cohesion MK Fund holds 4.07% worth ₹82 Cr. M-Cap is ₹2100 Cr. Promoters hold 37%. Co is dominant in branded Home Textile with a 'fibre to shelf' model
  • Suraj Estate Developers has a robust project lineup & launch pipeline. TP ₹992 (+73%)
    Suraj Estate Developers has a robust project lineup & launch pipeline, leadership position in redevelopment projects, strong cost advantage, proven track record, huge addressable market and healthy Balance Sheet with predictable cash flows. TP ₹992 (+73%) Download research report... Suraj Estate Developers has a robust project lineup & launch pipeline. TP ₹992 (+73%)
  • DCX Systems has the ability to become a key player in EMS space. TP ₹466 (+54%)
    DCX Systems has the ability to become a key player in EMS space with huge potential in railway & defence. It has ability to deliver high value complicated & critical products for leading defense players L&T & Lockheed. Order book ₹3000 Cr. TP ₹466 (+54%) Download... DCX Systems has the ability to become a key […]
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!